SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-033940
Filing Date
2019-09-04
Accepted
2019-09-04 09:00:21
Documents
4
Period of Report
2019-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20190829.htm 8-K 29035
2 EX-99.1 clsd-ex991_6.htm EX-99.1 36466
3 GRAPHIC gold44bx10qv000001.jpg GRAPHIC 3152
4 GRAPHIC gold44bx10qv000002.jpg GRAPHIC 2230
  Complete submission text file 0001564590-19-033940.txt   74421
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 191073400
SIC: 2834 Pharmaceutical Preparations